Stem Cell Therapy- An Overview

Authors

  • Aishwarya Goud Jagiri Department of Pharmacy Practice, Sree Chaitanya Institute of Pharmaceutical Sciences, Thimmapur, Karimnagar, Telangana, India.
  • Priyanka Gotte Department of Pharmacy Practice, Sree Chaitanya Institute of Pharmaceutical Sciences, Thimmapur, Karimnagar, Telangana, India.
  • Swetha Singireddy Department of Pharmacy Practice, Sree Chaitanya Institute of Pharmaceutical Sciences, Thimmapur, Karimnagar, Telangana, India.
  • Rohith Kumar Kadarla Department of Pharmacy Practice, Sree Chaitanya Institute of Pharmaceutical Sciences, Thimmapur, Karimnagar, Telangana, India.

DOI:

https://doi.org/10.22270/ajprd.v7i5.558

Keywords:

Stem cells, cell-based therapies, tissue regeneration.

Abstract

Stem cells are defined as cells that have clonogenic and self-renewing capabilities and differentiate into multiple cell lineages. Stem cells are found in all of us, from the early stages of human development to the end of life. According to differentiation potential stem cells are divided into 5 types: totipotent, pluripotent, multipotent, oligopotent and unipotent. They are vital to the development, growth, maintenance, and repair of our brains, bones, muscles, nerves, blood, skin, and other organs. Stem cell therapy is emerging as a potentially revolution­ ary new way to treat disease and injury, with wide-ranging medical benefits. Stem cell research presents many ethical and scientific questions as well as future challenges. Stem cell therapy, a prologue to an era of medical discovery of cell-based therapies that will one day restore function to those whose lives are now challenged every day, is still at the beginning of the road. . Stem cells have great potential in tissue regeneration and repair but much still needs to be learned about their biology, manipulation and safety before their full therapeutic potential can be achieved.

 

Downloads

Download data is not yet available.

Author Biographies

Aishwarya Goud Jagiri, Department of Pharmacy Practice, Sree Chaitanya Institute of Pharmaceutical Sciences, Thimmapur, Karimnagar, Telangana, India.

Department of Pharmacy Practice, Sree Chaitanya Institute of Pharmaceutical Sciences, Thimmapur, Karimnagar, Telangana, India.

Priyanka Gotte, Department of Pharmacy Practice, Sree Chaitanya Institute of Pharmaceutical Sciences, Thimmapur, Karimnagar, Telangana, India.

Department of Pharmacy Practice, Sree Chaitanya Institute of Pharmaceutical Sciences, Thimmapur, Karimnagar, Telangana, India.

Swetha Singireddy, Department of Pharmacy Practice, Sree Chaitanya Institute of Pharmaceutical Sciences, Thimmapur, Karimnagar, Telangana, India.

Department of Pharmacy Practice, Sree Chaitanya Institute of Pharmaceutical Sciences, Thimmapur, Karimnagar, Telangana, India.

Rohith Kumar Kadarla, Department of Pharmacy Practice, Sree Chaitanya Institute of Pharmaceutical Sciences, Thimmapur, Karimnagar, Telangana, India.

Department of Pharmacy Practice, Sree Chaitanya Institute of Pharmaceutical Sciences, Thimmapur, Karimnagar, Telangana, India.

References

1. Kalra K and Tomar PC, Stem Cell: Basics, Classification and Applications. American Journal of Phytomedicine and Clinical Therapeutics, AJPC.2014; 2(7)919-930
2. Hans R. The potential of stem cells: An inventory. Human biotechnology as Social Challenge, England, Ashgate Publishing, Ltd. 2007; 28.
3. www.medicalnewstoday.com/info/stem_cell.
4. www.findingtruthmatters.org/articles/stem- cell.
5. Jesse K. Biehl, BS, Brenda Russell Introduction to Stem Cell Therapy, J Cardiovasc Nurs. 2009; 24(2):98–105.
6. Laflamme MA, Chen KY, Naumova AV, et al. Cardiomyocytes derived from human embryonic stem cells in pro-survival factors enhance function of infracted rat hearts. Nat Biotechnol. 2007; 25(9):1015–24.
7. Wernig M, Zhao JP, Pruszak J, et al. Neurons derived from reprogrammed fibroblastfunctionally integrate into the fetal brain and improve symptoms of rats with parkinson’s disease. Proc Natl Acad Sci USA. 2008; 105(15):5856–61
8. Darabi R, Gehlbach K, Bachoo RM, et al. Functional skeletal muscle regeneration from differentiating embryonic stem cells. Nat Med. 2008; 14(2):134–43.
9. Laflamme MA, Gold J, Xu C, et al. Formation of human myocardium in the rat heart from human embryonic stem scells. Am J Pathol. 2005; 167(3):663–71.
10. Kehat I, Khimovich L, Caspi O, et al. Electromechanical integration of cardiomyocytes derived from human embryonic stem cells. Nat Biotechnol. 2004; 22(10):1282–89.
11. Xue T, Cho HC, Akar FG, et al. Functional integration of electrically active cardiac derivatives from genetically engineered human embryonic stem cells with quiescent recipient ventricular cardiomyocytes: insights into the development of cell-based pacemakers. Circulation. 2005; 111(1):11–20.
12. Engler AJ, Sen S, Sweeney HL, Discher DE. Matrix elasticity directs stem cell lineage specifications. Cell. 2006; 126(4):677–89.
13. Alhadlaq A, Mao JJ. Tissue-engineered osteochondral constructs in the shape of an articular condyle. J Bone Joint Surg Am. 2005; 87(5):936–44.
14. I. Singec, R. Jandial, A. Crain, G. Nikkhah and E.Y. Snyder, "The leading edge of stem cell therapeutics". Annu. Rev. Med. 58, 2007; 313–328.
15. C. Jahoda. And A. Reynolds, “Skin stem cells — a hairy issue.” Nature Medicin,e 2000; 6:1095-1097.
16. Freed CR, Greene PE, Breeze RE, W-Y Tsai, W. Du Moucel, R. Kao, S. Dillon, H. Winfield, S. Culver, J.Q. Trojanowski, D. Eidelberg and S. Fahn, “Transplantation of embryonic dopamine neurons for severe parkinson’s disease” New England J. of. Med.2000; 344:710-719.
17. N. Lumelsky, O. Blondel, P. Laeng, I. Velasco, R. Ravin and R. McKay, “Differentiation of embryonic stem cells to insulin-secreting structures similar to pancreatic islets” Science,2001;292: 1389- 1394.
18. Kumar S, Singh NP, Stem cells: A new paradigm Indian Journal of Human Genetics, 2006; 12(1).
19. Okano H, Okada S, Nakamura M. Neural stem cells and regeneration of injured spinal cord. Kidney Int 2005; 68:1927-31.
20. Wollaret KC. BOOST trial (Bone marrow transfer to en­ hance ST-elevation infarct). Lancet 2004; 364.
21. Mathur A, Martin JF. Stem cells and repair of the heart. Lancet 2004; 364:183-92.
22. Monogr. Stem cell and HIV infection. J Natl Cancer Inst 2000; 28:24-9.
23. Jeffrey MK, Ponzetti M, David SA, stem cells An Interactive Qualifying Project Report, Submitted to the Faculty of worcester polytechnic institute In partial fulfillment of the requirements for the Degree of Bachelor of Science, 2006. AJPCT, 2014; 2(7):919-930.
24. S. Avasthi, R. N. Srivastava, A. Singh and M. Srivastava “Stem cells: Past, Present, Future – a review article”, Internaet J. Med. Update, 2008, 3(1):22-30.
25. juanv.files.wordpress.com/.../stemcells2-gif.
26. www.nature.com/.../images/nature06800- f2.2.jpg
27. Schöler HR, "The Potential of Stem Cells: An Inventory". In Nikolaus Knoepffler, Dagmar Schipanski, and Stefan Lorenz Sorgner. Humanbiotechnology as Social Challenge. Ashgate Publishing, Ltd. 2007,march 2011, volume 1 ,page.no 380.
28. Ulloa-Montoya L, Verfaillie CM, and W.S Hu, "Culture systems for pluripotent stem cells". J Biosci Bioeng, 100 (1), 2005, 12–27.
29. www.kumc.edu/stemcell/images/stemce llscomefrom.jpg
30. http://gslc.genetics.utah.edu/units/stemcells/sc create
31. Carla A Herberts1, Marcel SG Kwa2 , Harm PH Hermsen1 Risk factors in the development of stem cell therapy Herberts et al. Journal of Translational Medicine 2011, 9:29.
32. www.cancer.gov/about-cancer/treatment/types/stem-cell-transplant#2
33. www.cancer.org/treatment/treatments-and-side-effects/treatment-types/stem-cell-transplant/transplant-side-effects.
34. www.mskcc.org/cancer-care/patient-education/returning-home-after-your-autologous-stem-cell-transplant.

Published

2019-10-15

How to Cite

Jagiri, A. G., Gotte, P., Singireddy, S., & Kadarla, R. K. (2019). Stem Cell Therapy- An Overview. Asian Journal of Pharmaceutical Research and Development, 7(5), 92–102. https://doi.org/10.22270/ajprd.v7i5.558